Factor V Leiden mutation in Arabs in Kuwait by real-time PCR: different values for different Arabs
- PMID: 20224595
- DOI: 10.1038/jhg.2010.11
Factor V Leiden mutation in Arabs in Kuwait by real-time PCR: different values for different Arabs
Abstract
Factor V Leiden (FVL) mutation (G1691A) is a risk factor for development of venous thromboembolic disorders. FVL was found mostly in Caucasians (1-15%) but was almost absent in non-Caucasians. Studies on Arab patients and populations revealed very inconsistent results. This study reports FVL in Arabs living in Kuwait with a focus on the nationality of the Arab subjects studied. Whole-blood samples were collected from 400 healthy Arabs who were 268 Kuwaitis (67%), 50 Syrians (12.5%), 34 Jordanians (8.5%), 8 Palestinians (2%) and 40 Egyptians (10%). DNA extraction was carried out for these blood samples and real-time PCR was performed to detect the presence of FVL. Generally, 36 cases (9%) had the mutation (33 were heterozygous and 3 were homozygous), with an allelic frequency of 0.049. The prevalence of FVL differed in different Arabic cases: Kuwaitis 4.5%, Egyptians 15%, Syrians 16%, Jordanians 23.5% and Palestinians 25%. The allelic frequency was 0.022 in the Kuwaitis and 0.088-0.132 in non-Kuwaitis. The three homozygous cases were from Syria, Jordan and Egypt. In conclusion, the prevalence of FVL in Arabs living in Kuwait is as high as in Caucasians. There is a difference in prevalence among Arabs themselves, being relatively lower in Kuwaitis than in non-Kuwaitis.
Similar articles
-
Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals.Mol Biol Rep. 2011 Aug;38(6):3623-8. doi: 10.1007/s11033-010-0474-7. Epub 2010 Nov 21. Mol Biol Rep. 2011. PMID: 21104134
-
Thrombosis risk in carriers of the factor V Leiden mutation: is it associated with a defined skin color?Pathol Res Pract. 2011 Nov 15;207(11):671-3. doi: 10.1016/j.prp.2011.07.013. Epub 2011 Oct 13. Pathol Res Pract. 2011. PMID: 21996318
-
Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.Neuro Endocrinol Lett. 2007 Oct;28(5):699-703. Neuro Endocrinol Lett. 2007. PMID: 17984931
-
Autosomal recessive disorders among Arabs: an overview from Kuwait.J Med Genet. 1994 Mar;31(3):224-33. doi: 10.1136/jmg.31.3.224. J Med Genet. 1994. PMID: 8014972 Free PMC article. Review.
-
Genetic epidemiology of male infertility (MI) in Arabs: a systematic review.Reprod Fertil Dev. 2022 Sep;34(14):905-919. doi: 10.1071/RD21343. Reprod Fertil Dev. 2022. PMID: 36041737
Cited by
-
Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.Mediterr J Hematol Infect Dis. 2011;3(1):e2011037. doi: 10.4084/MJHID.2011.037. Epub 2011 Sep 8. Mediterr J Hematol Infect Dis. 2011. PMID: 22224194 Free PMC article.
-
Factor V Leiden, prothrombin 20210G>A, MTHFR 677C>T and 1298A>C, and homocysteinemia in Tunisian blood donors.J Clin Lab Anal. 2012 May;26(3):167-73. doi: 10.1002/jcla.21506. J Clin Lab Anal. 2012. PMID: 22628232 Free PMC article.
-
Prevalence of the Factor V Leiden Mutation Arg534Gln in Western Region of Saudi Arabia: Functional Alteration and Association Study With Different Populations.Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029620978532. doi: 10.1177/1076029620978532. Clin Appl Thromb Hemost. 2021. PMID: 33448877 Free PMC article.
-
Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals.Mol Biol Rep. 2011 Aug;38(6):3623-8. doi: 10.1007/s11033-010-0474-7. Epub 2010 Nov 21. Mol Biol Rep. 2011. PMID: 21104134
-
The prevalence of Factor V Leiden (Arg506Gln) mutation in King Khalid University Hospital patients, 2017-2019.Nagoya J Med Sci. 2021 Aug;83(3):407-417. doi: 10.18999/nagjms.83.3.407. Nagoya J Med Sci. 2021. PMID: 34552279 Free PMC article.